VIDAS® TB-IGRA reagents induce a CD4+ and CD8+ T-cell IFN-γ response for both TB infection and active TB-Reference-Cited by-同舟云学术

VIDAS® TB-IGRA reagents induce a CD4+ and CD8+ T-cell IFN-γ response for both TB infection and active TB

Published:2022-01-01 Issue:1 Volume:26 Page:65-68
ISSN:1027-3719
Container-title:The International Journal of Tuberculosis and Lung Disease
language:en
Short-container-title:int j tuberc lung dis

Author:

Petruccioli E.¹,Farroni C.¹,Cuzzi G.¹,Vanini V.²,Palmieri F.³,Vittozzi P.³,Goletti D.¹

Affiliation:

1. Translational Research Unit, National Institute for Infectious Diseases Lazzaro Spallanzani, Istituto di Ricovero e Cura a Carattere Scientifico, Rome, Italy

2. Translational Research Unit, National Institute for Infectious Diseases Lazzaro Spallanzani, Istituto di Ricovero e Cura a Carattere Scientifico, Rome, Italy, UOS Professioni Sanitarie Tecniche, National Institute for Infectious Diseases Lazzaro Spallanzani, Istituto di Ricovero e Cura a Carattere Scientifico, Rome, Italy

3. Respiratory Infectious Diseases Unit, National Institute for Infectious Diseases Lazzaro Spallanzani, Istituto di Ricovero e Cura a Carattere Scientifico, Rome, Italy

Publisher

International Union Against Tuberculosis and Lung Disease

Subject

Infectious Diseases,Pulmonary and Respiratory Medicine

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tuberculosis Diagnosis: Current, Ongoing, and Future Approaches;Diseases;2024-09-03

2. VIDAS^®TB-IGRA accuracy in tuberculosis patients and persons at varying risk of exposure;2024-07-05

3. Expression of HLA-DR and KLRG1 enhances the cytotoxic potential and cytokine secretion capacity of CD3+ T cells in tuberculosis patients;International Immunopharmacology;2024-05

4. High Manganese Content of Lipid NanoMn (LNM) by Microfluidic Technology for Enhancing Anti-Tumor Immunity;Pharmaceutics;2024-04-19

5. Advancing Understanding of Childhood Asthma: Lessons Learned from Birth Cohort Studies;Clinical Reviews in Allergy & Immunology;2024-02-07